Clinical Trial Update: Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Depocyte for CNS relapse in patients with acute lymphoblastic leukemia and aggressive lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoma

Drugs mentioned

• Depocyte

Snippet

Sponsor: PETHEMA Foundation | Conditions: Lymphoblastic Leukemia, Lymphoma | Phase 2 | Status: COMPLETED